Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Spero Therapeutics, Inc. | Chief Medical Officer | Common Stock | 788K | $1.08M | $1.37 | Feb 2, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRO | Spero Therapeutics, Inc. | Feb 1, 2024 | 2 | -$38.5K | 4 | Feb 5, 2024 | Chief Medical Officer |
SPRO | Spero Therapeutics, Inc. | Sep 13, 2023 | 1 | -$50.2K | 4 | Sep 15, 2023 | Chief Medical Officer |
SPRO | Spero Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Chief Medical Officer |
SPRO | Spero Therapeutics, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 3, 2023 | Chief Medical Officer |
SPRO | Spero Therapeutics, Inc. | Sep 12, 2022 | 1 | $0 | 4 | Sep 14, 2022 | Chief Medical Officer |
SPRO | Spero Therapeutics, Inc. | Sep 12, 2022 | 0 | $0 | 3 | Sep 14, 2022 | Chief Medical Officer |